Heather E. Stefanski

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia”.

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0095

N/A

0.785DataRank · unranked

186 citations

Xia Han, Shannon L. Maude, Theodore W. Laetsch, Muna Qayed, Susana Rives +17 more

Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT

Bone Marrow Transplantation(2024)10.1038/s41409-024-02251-0

N/A

0.631DataRank · unranked

66 citations

Paul A. Carpenter, Andrea Bacigalupo, Vijaya Raj Bhatt, Josu de la Fuente, Aloysius Ho +17 more

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

Blood Advances(2023)10.1182/bloodadvances.2022008893

N/A

0.515DataRank · unranked

30 citations

Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J. Chen +28 more

P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss

PLoS ONE(2022)10.1371/journal.pone.0261770

N/A

0.396DataRank · unranked

13 citations

Yan Xing, Jemma Nicholls, Leslie M. Jonart, Emily Goren, Patricia A. Taylor +7 more

The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.042

N/A

0DataRank · unranked

9 citations

Kwang Woo Ahn, Stephanie Bo‐Subait, Brent R. Logan, Heather E. Stefanski, Jack W. Hsu +20 more

Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.007

N/A

0DataRank · unranked

71 citations

Jianqun Kou, Min Chen, Yung‐Tsi Bolon, Larisa Broglie, Caitrin Bupp +23 more

Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease

UNC Libraries(2020)10.17615/6852-fq76

N/A

0DataRank · unranked

1 citations

Benjamin G. Vincent, Paul M. Armistead, Jonathan S. Serody, Bruce R. Blazar, James M. Coghill +13 more

Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia

American Journal of Hematology(2023)10.1002/ajh.26834

N/A

0DataRank · unranked

24 citations

Brent R. Logan, Stephanie Bo‐Subait, Amer Beitinjaneh, Steven M. Devine, Nosha Farhadfar +13 more

A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.02.010

N/A

0DataRank · unranked

5 citations

Eric Huselton, Heather E. Stefanski, Todd E. DeFor, Ryan Shanley, Jaebok Choi +6 more

Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide

Blood Advances(2025)10.1182/bloodadvances.2025017194

N/A

0DataRank · unranked

6 citations

Yosra Aljawai, Todd E. DeFor, Caitrin Bupp, Monzr M. Al Malki, Javier Bolaños‐Meade +14 more

Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel

Blood Advances(2025)10.1182/bloodadvances.2025016824

N/A

0DataRank · unranked

2 citations

Subodh Selukar, Aimee C. Talleur, Samira Deshpande, Gabriela Llaurador Caraballo, Vanessa A. Fabrizio +34 more

A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD

Blood Advances(2025)10.1182/bloodadvances.2024013609

N/A

0DataRank · unranked

2 citations

Sonia J. Laurie, Yan Xing, Heather E. Stefanski, Keli L. Hippen, Alec D. Wilkinson +6 more

Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD

Blood Advances(2021)10.1182/bloodadvances.2020001514

N/A

0DataRank · unranked

17 citations

Oleg Kolupaev, Sonia J. Laurie, Hemamalini Bommiasamy, Heather E. Stefanski, Bruce R. Blazar +3 more

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2022)10.1200/jco.22.01076

N/A

0DataRank · unranked

73 citations

Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K. Keating +26 more

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021006418

N/A

0DataRank · unranked

113 citations

Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler +27 more